Kezar Life Sciences, Inc. (KZR) Tops Q3 EPS by 5c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q3 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Ciena beats estimates on strong AI-driven demand, shares rise
• HF Foods acquires Canadian seafood distributor Searay Foods for ~$35M
• Victoria’s Secret shares slump 16% on weak Q3 operating income outlook